2. Academic Validation
  3. Targeted Intracellular Copper Reservoir Enhances Liver Cancer Immunotherapy

Targeted Intracellular Copper Reservoir Enhances Liver Cancer Immunotherapy

  • Small. 2025 Sep;21(36):e02783. doi: 10.1002/smll.202502783.
Tianao Xie 1 2 3,  Yukai Shan 1 2 3,  Win Topatana 1 2 3,  Taorui Yang 4,  Ruijing Shen 1 2 3,  Shijie Li 1 2 3,  Jiadong Chen 5,  Yiyuan Zhu 6,  Ziyi Lu 1 2 3,  Yeling Liu 7,  Tianen Chen 1 2 3,  Yujie Gao 8,  Yuchao Sun 1 2 3,  Xiujun Cai 1 2 3,  Sarun Juengpanich 1 2 3,  Mingyu Chen 1 2 3 9
Affiliations

Affiliations

  • 1 Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University, Hangzhou, 310016, P. R. China.
  • 2 National Engineering Research Center of Innovation and Application of Minimally Invasive Instruments, Sir Run-Run Shaw Hospital, Zhejiang University, Hangzhou, 310016, P. R. China.
  • 3 School of Medicine, Zhejiang University, Hangzhou, 310058, P. R. China.
  • 4 College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, P. R. China.
  • 5 Department of Chemistry, Zhejiang University, Hangzhou, 310016, P. R. China.
  • 6 School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310058, P. R. China.
  • 7 Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Beijing, 100730, P. R. China.
  • 8 Rizhao Emergency Management Support Center, Rizhao, 276800, P. R. China.
  • 9 State Key Laboratory of Advanced Drug Delivery and Release Systems, Shandong Luye Pharmaceutical Co., Ltd., Yantai, Shandong, 264003, P. R. China.
PMID: 40685755 DOI: 10.1002/smll.202502783
Abstract

Hepatocellular carcinoma (HCC) is commonly classified as a "cold tumor" due to its low immunogenicity and poor response to conventional immunotherapies. Reprogramming the tumor immune microenvironment (TIME) via Cuproptosis presents a promising strategy to enhance immunotherapies. Herein, sono-activatable N,N,N',N'-tetrakis(2-pyridinylmethyl)-1,2-ethanediamine (TPEN)-encapsulated cancer-targeted nanoparticles (STCNs) designed to modulate the TIME and potentiate immunotherapy through endogenous Cuproptosis are reported, termed "endogenous Cuproptosis immunopromotion". STCNs are rapidly internalized by HCC via folate-mediated endocytosis, and ultrasound irradiation triggers the release of TPEN. TPEN then chelates Cu2⁺ from superoxide dismutase, initiating a Fenton-like reaction induced by glutathione that produces Reactive Oxygen Species (ROS) and Cu⁺. This cascade induces Cuproptosis and immunogenic cell death (ICD), promoting robust cytotoxic T lymphocyte infiltration in HCC. The combination of STCNs with anti-programmed cell death protein 1 (PD1) therapy demonstrates significant anti-tumor efficacy in vivo. Moreover, this strategy exhibits similar effectiveness in Other solid tumor models, underscoring its broad therapeutic potential. These findings provide a promising framework for enhancing immunotherapy in cold tumors, paving the way for future Cancer treatments.

Keywords

cuproptosis; hepatocellular carcinoma; immunogenic cell death; metal‐organic frameworks; sonodynamic therapy.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z